Clinical trial
A Randomized Controlled Trial to Evaluate the Clinical Benefits of EnvarsusXR in Post Liver Transplant
NCT03386305 is registered in ClinicalTrials.gov with Albert Einstein Healthcare Network as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized Controlled Trial to Evaluate the Clinical Benefits of EnvarsusXR in Post Liver Transplant
- Lead sponsor
- Albert Einstein Healthcare Network
- Phase
- Phase 2/3
- Overall status
- Active, not recruiting
- Start date
- December 13, 2017
- Completion date
- December 31, 2021
- Enrollment
- 35 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
post liver transplant